Delivery Order SPE2DB24D1205-SPE2DB25FCZSN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,829.29 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $32,625.43 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 20, 2025. This is a firm fixed-price, non-set-aside contract executed on August 19, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $39,328.20 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Prolia 60 mg/mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $19,857.04 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with a firm fixed price contract type and ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,459.35 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price terms and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office...
- The Defense Logistics Agency awarded a $36,928.09 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract executed on July 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a $57,441.34 delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Prolia 60 mg/mL syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, with fulfillment taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical supplies supporting federal medical procurement needs, primarily for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,214.35 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringe on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location in the same...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZSNDelivery Order
The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle that runs through December 2026 and serves as a comprehensive global procurement mechanism for military healthcare systems. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is a critical vendor for federal medical procurement. The company's extensive federal contract portfolio demonstrates consistent capability in supplying pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. This delivery order for Prolia, a bone health medication, reflects the company's role in fulfilling DLA's pharmaceutical distribution requirements across multiple therapeutic domains through competitive procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 8/19/25 |